Structure Therapeutics Inc. American Depositary Shares Earnings Dividend

Structure Therapeutics Inc. American Depositary Shares’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2026. On a quarterly growth basis, Structure Therapeutics Inc. American Depositary Shares has generated NaN% jump in its revenue since last 3-months.

Structure Therapeutics Inc. American Depositary Shares’s net profit fell -72.17% since last year same period to $-106.16Mn in the Q2 2026. On a quarterly growth basis, Structure Therapeutics Inc. American Depositary Shares has generated -39.33% fall in its net profits since last 3-months.

Structure Therapeutics Inc. American Depositary Shares’s net profit margin jumped NaN% since last year same period to -Inf% in the Q2 2026. On a quarterly growth basis, Structure Therapeutics Inc. American Depositary Shares has generated NaN% jump in its net profit margins since last 3-months.

Structure Therapeutics Inc. American Depositary Shares’s earning per share (EPS) estimates for the current quarter stand at -0.51 - a -30.77% fall from last quarter’s estimates.

Structure Therapeutics Inc. American Depositary Shares’s earning per share (EPS) estimates for the current year stand at -0.51.

Structure Therapeutics Inc. American Depositary Shares’s earning per share (EPS) fell -36.11% since last year same period to -0.49 in the Q2 2026. This indicates that the Structure Therapeutics Inc. American Depositary Shares has generated -36.11% annual rate of fall in its earning per share (EPS) in the last 4 quarters.